Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United States
Cynthia Z. Qi, Vamsi Bollu, Hongbo Yang, Anand A. Dalal, Su Zhang, Jie Zhang
Topics & Concepts
MedicineOncologyInternal medicineDiffuse large B-cell lymphomaSurvival analysisCost effectivenessLymphomaRisk analysis (engineering)CAR-T cell therapy researchLymphoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia research